Article

ACCC Publication Offers Insight for Incorporating Immunotherapies Into Practice

The Association of Community Cancer Centers (ACCC) has released a new report highlighting resources developed by the ACCC Immuno-Oncology Institute to meet the needs of detailed, practical insights for selecting and delivering immunotherapy, recognizing and managing immune-related toxicities, and coordinating patient care across specialties.

The Association of Community Cancer Centers (ACCC) has released a new report highlighting resources developed by the ACCC Immuno-Oncology Institute to meet the needs of detailed, practical insights for selecting and delivering immunotherapy, recognizing and managing immune-related toxicities, and coordinating patient care across specialties. Targeted materials developed by the institute include a how-to guide for developing an interdisciplinary toxicity team to help manage immune-related adverse events, as well as workshops and webinars focused on effective practices for multidisciplinary teams delivering these new therapies.

See more highlights from the report.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Dr Margrit Wiesendanger
Ibrahim Aldoss, MD, associate professor, City of Hope
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
Cathy Eng, MD, FACP, FASCO
Dr Margrit Wiesendanger
Nini Wu, MD, Navista
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Dr Margrit Wiesendanger
Tom Belmon, CAP, GPBCH
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo